European Archives - Page 941 of 1159 - European Medical Journal

3D-Printed Models: The Future of Heart Valve Replacement

OUTCOMES of heart valve replacements could be revolutionised through the use of three-dimensional (3D)-printed models, which could boost the success of…

EMJ

More Frequent Haemodialysis Improved Outcomes: The Wish Comes True at Home

This satellite symposium reviewed the challenges in providing dialysis to patients with kidney disease and outlined data supporting the effectiveness of…

Helsinn Group and MEI Pharma Announce First Patient Dosed in Pivotal Phase 3 Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia

Lugano, Switzerland and San Diego, USA, 2 August, 2017 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products…

Introducing EMJ Allergy & Immunology 2.1

United Kingdom, August 03, 2017: EMJ would like to welcome you to the latest edition of EMJ Allergy and Immunology. This much-anticipated eJournal…

EMJ Allergy & Immunology 2.1 2017

EMJ would like to welcome you to the latest edition of EMJ Allergy and Immunology. This much-anticipated eJournal contains a comprehensive summary…

Review of the 61st European Academy of Allergy and Clinical Immunology Congress 2017

The largest allergy congress in the world was this year hosted in the scenic city of Helsinki, Finland.

Rapid Desensitisation for the Management of Hypersensitivity Reaction to Biologicals: Infliximab and Adalimumab in Inflammatory Bowel Disease Patients

Biologicals in the treatment of inflammatory bowel disease are important, but their usefulness is limited in patients with hypersensitivity reaction.

Hypersensitivity to Natural Rubber Latex gloves among Albanian Dental Students

Latex allergy is a common occupational disease among healthcare workers who use latex gloves. Read more about it

Skin Prick Reactivity to 80 Different Allergens Among 144 Medical Students in Birjand, Iran

Allergic disorders are among the most prevalent health problems around the world, particularly in low and middle-income countries.

Future of the Allergists and Allergen Specific Immunotherapy (FASIT) Meets EACCI

The FASIT meetings ensure conversations do not remain as just academic discussions in ivory towers, but are shared widely throughout the world